https://www.mdpi.com/2077-0383/13/5/1337
Anti-Anginal Efficacy of Zibotentan in the Coronary Slow-Flow Phenomenon
Background: Patients with coronary microvascular disorders often experience recurrent angina for which there are limited evidence-based therapies. These...
anti anginalslow flowefficacy
https://spiral.imperial.ac.uk/entities/publication/734d6a6c-a149-424c-a112-e33004526bcb
Anti-anginal drugs - belief and evidence: systematic review covering 50 Years of medical treatment
Chronic stable angina is the most prevalent symptom of ischaemic heart disease and its management is a priority. Current guidelines recommend pharmacological...